TMO is Thermo Fisher Scientific Inc. (Healthcare). Trading at $448.28. Current dividend yield: 0.42%.
Dividend snapshot
| Annual dividend rate | $1.76 |
| Current yield | 0.42% |
| Payment frequency | Quarterly |
| Next ex-dividend date | Jun 15, 2026 |
| Most recent payment date | Apr 15, 2026 |
| Last payment amount | $0.4700 |
| 5-year dividend CAGR | 14.34% |
| 3-year dividend CAGR | 12.75% |
| Payout ratio | 10% |
| Market cap | $166.59B |
| Exchange | NYQ |
Recent dividend payments
| Date | Amount / share |
|---|---|
| 2026-03-13 | $0.4700 |
| 2025-12-15 | $0.4300 |
| 2025-09-15 | $0.4300 |
| 2025-06-13 | $0.4300 |
| 2025-03-14 | $0.4300 |
| 2024-12-13 | $0.3900 |
| 2024-09-13 | $0.3900 |
| 2024-06-14 | $0.3900 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Track TMO in DiviDrip
Add TMO to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.
- Open DiviDrip — search TMO and add your shares.
- View the TMO Dividend Triangle — see Revenue × EPS × Dividend growth at a glance.
- Stock Screener — find more dividend payers like TMO.
- DiviDrip Learn — free guides on DRIP, dividend tiers, ETF comparisons.
Data refreshed 2026-05-23. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.